OptiBiotix Health plc (OPTI) Ord 2p
- Add to watchlist
- Create an alert
- This stock can be held in a
19.25p
19.18p
33.75p
£17.38 million
19.25p
17.04p
10.25p
n/a
0.25p (1.32%) Previous:
0.25p
744,621
n/a
20,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (£m) | 0.64 | 0.46 |
Profit before tax (£m) | (2.04) | 2.44 |
Adjusted EPS (p): | (2.24) | 2.93 |
P/E ratio | n/a | 4.50 |
PEG | n/a | n/a |
EPS growth (%) | n/a | (59.00) |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
OptiBiotix to launch new range with India partner
3 December 2024 13:49
-
OptiBiotix reports 21pc decline in first-half revenue
27 September 2024 12:43
-
OptiBiotix reports solid first-half operational progress
20 August 2024 11:47
-
Issue of Options
20 December 2024 12:00
-
Holding(s) in Company
12 December 2024 14:45
-
Launch of Dr Morepen LightLife in India
3 December 2024 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.